{"hands_on_practices": [{"introduction": "Spirometry is the most common and essential tool for diagnosing and monitoring Chronic Obstructive Pulmonary Disease (COPD). Once airflow obstruction is confirmed, the next critical step is to quantify its severity. This exercise [@problem_id:4970339] provides hands-on practice in calculating key spirometric parameters, such as the percent predicted Forced Expiratory Volume in one second ($FEV_1$), and applying the globally recognized Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria to stage the disease. Mastering this calculation is fundamental for translating raw test data into a clinically meaningful assessment of COPD severity.", "problem": "A spirometry assessment informs population-level management of Chronic Obstructive Pulmonary Disease (COPD) within the Global Initiative for Chronic Obstructive Lung Disease (GOLD). For a patient whose predicted values are derived from validated reference equations such as the Global Lung Function Initiative (GLI), consider the following post-bronchodilator measurements: predicted forced expiratory volume in one second ($FEV_1^{pred}$) is $2.8$ liters, predicted forced vital capacity ($FVC^{pred}$) is $3.5$ liters, observed $FEV_1$ is $1.4$ liters, and observed $FVC$ is $2.6$ liters. Assume airflow obstruction has been established independently, so GOLD severity staging can be applied based solely on $FEV_1$ percent predicted.\n\nUse the following foundational definitions and widely accepted classification facts:\n\n- Percent predicted for a spirometric variable $X$ is defined as the unitless ratio $X^{obs}/X^{pred}$, where $X^{obs}$ is the observed value and $X^{pred}$ is the predicted value for the individualâ€™s demographic and anthropometric profile.\n- GOLD severity staging is categorized by $FEV_1$ percent predicted (unitless decimal) as follows: GOLD $1$ if $FEV_1\\% \\geq 0.80$, GOLD $2$ if $0.50 \\leq FEV_1\\%  0.80$, GOLD $3$ if $0.30 \\leq FEV_1\\%  0.50$, and GOLD $4$ if $FEV_1\\%  0.30$.\n\nCompute the percent predicted values for $FEV_1$ and $FVC$, then determine the GOLD severity stage number based on the $FEV_1$ percent predicted. Express the final answer as a row matrix containing three entries in the order $\\left[FEV_1\\%,\\,FVC\\%,\\,G\\right]$, where $G$ is the GOLD stage encoded numerically as $1$, $2$, $3$, or $4$. Express percent predicted values as unitless decimals, rounded to four significant figures. Do not include a percentage sign.", "solution": "The user has provided a problem that requires the calculation of spirometric parameters and the classification of COPD severity according to the GOLD guidelines.\n\n**Problem Validation**\n\n**Step 1: Extract Givens**\n- Predicted forced expiratory volume in one second: $FEV_1^{pred} = 2.8$ liters\n- Predicted forced vital capacity: $FVC^{pred} = 3.5$ liters\n- Observed forced expiratory volume in one second: $FEV_1^{obs} = 1.4$ liters\n- Observed forced vital capacity: $FVC^{obs} = 2.6$ liters\n- Premise: Airflow obstruction has been established independently.\n- Definition 1: Percent predicted for a spirometric variable $X$ is the unitless ratio $X^{obs} / X^{pred}$.\n- Definition 2: GOLD severity staging criteria based on $FEV_1$ percent predicted ($FEV_1\\%$):\n  - GOLD 1: $FEV_1\\% \\geq 0.80$\n  - GOLD 2: $0.50 \\leq FEV_1\\%  0.80$\n  - GOLD 3: $0.30 \\leq FEV_1\\%  0.50$\n  - GOLD 4: $FEV_1\\%  0.30$\n- Task: Compute $FEV_1\\%$ and $FVC\\%$ (rounded to four significant figures) and determine the numerical GOLD stage $G$.\n- Output Format: A row matrix $\\left[FEV_1\\%,\\,FVC\\%,\\,G\\right]$.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem is based on standard, internationally recognized clinical guidelines for the diagnosis and management of COPD (the GOLD strategy). The variables ($FEV_1$, $FVC$), definitions (percent predicted), and classification scheme are staples of respiratory medicine. The given values are physiologically plausible for a patient with moderate obstructive lung disease.\n- **Well-Posed:** The problem is self-contained. It provides all necessary numerical data and the explicit classification rules required to arrive at a unique solution. The rounding instruction is unambiguous.\n- **Objective:** The language is clinical and quantitative, devoid of any subjectivity or opinion.\n\n**Step 3: Verdict and Action**\nThe problem is valid as it is scientifically grounded, well-posed, and objective. A complete solution will be provided.\n\n**Problem Solution**\n\nThe objective is to compute the percent predicted values for $FEV_1$ and $FVC$, and then to determine the GOLD severity stage. The final answer is to be presented as a row matrix containing these three values.\n\nFirst, we calculate the $FEV_1$ percent predicted, denoted as $FEV_1\\%$. According to the provided definition, this is the ratio of the observed value to the predicted value.\nThe given values are $FEV_1^{obs} = 1.4$ liters and $FEV_1^{pred} = 2.8$ liters.\n\n$$FEV_1\\% = \\frac{FEV_1^{obs}}{FEV_1^{pred}} = \\frac{1.4}{2.8}$$\n$$FEV_1\\% = 0.5$$\nThe problem requires this value to be expressed as a decimal rounded to four significant figures. Thus, we write $0.5$ as $0.5000$.\n\n$$FEV_1\\% = 0.5000$$\n\nSecond, we calculate the $FVC$ percent predicted, denoted as $FVC\\%$.\nThe given values are $FVC^{obs} = 2.6$ liters and $FVC^{pred} = 3.5$ liters.\n\n$$FVC\\% = \\frac{FVC^{obs}}{FVC^{pred}} = \\frac{2.6}{3.5}$$\n$$FVC\\% \\approx 0.74285714...$$\nRounding this result to four significant figures gives:\n\n$$FVC\\% = 0.7429$$\n\nThird, we determine the GOLD severity stage number, $G$. This classification is based solely on the value of $FEV_1\\%$, which we calculated to be $0.5000$. We compare this value against the provided GOLD staging criteria:\n- GOLD 1: $FEV_1\\% \\geq 0.80$\n- GOLD 2: $0.50 \\leq FEV_1\\%  0.80$\n- GOLD 3: $0.30 \\leq FEV_1\\%  0.50$\n- GOLD 4: $FEV_1\\%  0.30$\n\nOur calculated value $FEV_1\\% = 0.5000$ satisfies the condition for GOLD 2, as $0.50 \\leq 0.5000  0.80$. The numerical encoding for GOLD stage 2 is $G=2$.\n\nFinally, we assemble the results into the specified row matrix format $\\left[FEV_1\\%,\\,FVC\\%,\\,G\\right]$.\nSubstituting the calculated values, we get:\n$[0.5000, 0.7429, 2]$.", "answer": "$$\\boxed{\\begin{pmatrix} 0.5000  0.7429  2 \\end{pmatrix}}$$", "id": "4970339"}, {"introduction": "Chronic shortness of breath can arise from different underlying lung pathologies, primarily categorized as obstructive or restrictive. While spirometry provides initial clues, differentiating between these patterns often requires a more comprehensive assessment. This problem [@problem_id:4970326] presents a series of clinical vignettes that challenge you to interpret a full suite of pulmonary function test data, including lung volumes like Total Lung Capacity ($TLC$) and the Diffusing Capacity for Carbon Monoxide ($DLCO$). By analyzing these cases, you will learn to distinguish true restrictive lung disease from its mimics, a critical skill in differential diagnosis.", "problem": "A district hospital in a low-resource setting is expanding objective assessment of chronic respiratory symptoms by adding lung volume testing to routine spirometry. Three adults with chronic dyspnea and cough undergo standardized spirometry followed by body plethysmography for lung volumes and a measurement of Diffusing Capacity of the Lung for Carbon Monoxide (DLCO). All devices are calibrated, and quality control flags are recorded. For each patient below, interpret the pattern with respect to whether the physiologic impairment is most consistent with intrinsic restrictive lung disease versus obstructive disease or technique-related limitation. Select the single best option.\n\nPatient $X$:\n- $FEV_1 = 55\\%$ predicted, $FVC = 59\\%$ predicted.\n- $FEV_1/FVC = 0.93$.\n- Total Lung Capacity ($TLC$) $= 66\\%$ predicted.\n- Residual Volume ($RV$) $= 80\\%$ predicted.\n- $DLCO = 52\\%$ predicted.\n- Spirometry quality control: acceptable start of test, forced expiratory time $= 10$ seconds, reproducible maneuvers.\n\nPatient $Y$:\n- $FEV_1 = 50\\%$ predicted, $FVC = 52\\%$ predicted.\n- $FEV_1/FVC = 0.86$.\n- $TLC = 120\\%$ predicted.\n- $RV = 190\\%$ predicted.\n- $DLCO = 82\\%$ predicted.\n- Spirometry quality control: acceptable start of test, forced expiratory time $= 12$ seconds, reproducible maneuvers.\n\nPatient $Z$:\n- $FEV_1 = 48\\%$ predicted, $FVC = 49\\%$ predicted.\n- $FEV_1/FVC = 0.98$.\n- $TLC = 98\\%$ predicted.\n- $RV = 100\\%$ predicted.\n- $DLCO = 95\\%$ predicted.\n- Spirometry quality control: suboptimal; forced expiratory time $= 3$ seconds, early termination noted, poor reproducibility.\n\nWhich option best identifies the patient whose pattern is most consistent with intrinsic restrictive lung disease (parenchymal restriction) rather than obstructive disease or technique-related artifact?\n\nA. Patient $X$ shows intrinsic restrictive lung disease due to parenchymal involvement.\n\nB. Patient $Y$ shows intrinsic restrictive lung disease.\n\nC. Patient $Z$ shows intrinsic restrictive lung disease.\n\nD. None of the above; all patterns are obstructive or technique-related, not intrinsic restriction.", "solution": "The user has provided a clinical problem requiring the interpretation of pulmonary function tests (PFTs) for three patients to identify the one most consistent with intrinsic restrictive lung disease.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n\nThe problem provides the following data for three patients ($X$, $Y$, and $Z$) who have undergone spirometry, body plethysmography for lung volumes, and measurement of Diffusing Capacity of the Lung for Carbon Monoxide ($DLCO$):\n\n**Patient X:**\n- $FEV_1 = 55\\%$ predicted\n- $FVC = 59\\%$ predicted\n- $FEV_1/FVC = 0.93$\n- Total Lung Capacity ($TLC$) $= 66\\%$ predicted\n- Residual Volume ($RV$) $= 80\\%$ predicted\n- $DLCO = 52\\%$ predicted\n- Spirometry quality control: acceptable start of test, forced expiratory time $= 10$ seconds, reproducible maneuvers.\n\n**Patient Y:**\n- $FEV_1 = 50\\%$ predicted\n- $FVC = 52\\%$ predicted\n- $FEV_1/FVC = 0.86$\n- $TLC = 120\\%$ predicted\n- $RV = 190\\%$ predicted\n- $DLCO = 82\\%$ predicted\n- Spirometry quality control: acceptable start of test, forced expiratory time $= 12$ seconds, reproducible maneuvers.\n\n**Patient Z:**\n- $FEV_1 = 48\\%$ predicted\n- $FVC = 49\\%$ predicted\n- $FEV_1/FVC = 0.98$\n- $TLC = 98\\%$ predicted\n- $RV = 100\\%$ predicted\n- $DLCO = 95\\%$ predicted\n- Spirometry quality control: suboptimal; forced expiratory time $= 3$ seconds, early termination noted, poor reproducibility.\n\n**Question:**\nWhich option best identifies the patient whose pattern is most consistent with intrinsic restrictive lung disease (parenchymal restriction) rather than obstructive disease or technique-related artifact?\n\n**Step 2: Validate Using Extracted Givens**\n\nThe problem is evaluated against the validation criteria:\n\n1.  **Scientifically Grounded:** The problem is based on the established principles of respiratory physiology and the clinical interpretation of pulmonary function tests. The parameters ($FEV_1$, $FVC$, $TLC$, $RV$, $DLCO$) are standard measures, and their use in diagnosing obstructive versus restrictive lung disease is a cornerstone of pulmonology. The provided numerical values are clinically plausible.\n2.  **Well-Posed:** The problem is well-posed. It provides sufficient data for each patient to allow for a differential physiological diagnosis based on standard interpretive algorithms. The question is specific, asking to identify a particular pattern (intrinsic restrictive lung disease).\n3.  **Objective:** The problem is stated in objective, quantitative terms without subjective or opinion-based language. The quality control data adds an essential layer of objectivity to the interpretation.\n4.  **No Flaws:** The problem statement does not violate any of the listed flaws. It is not scientifically unsound, incomplete, contradictory, unrealistic, or ill-posed. The data provided for each patient profile are internally consistent and represent common clinical scenarios.\n\n**Step 3: Verdict and Action**\n\nThe problem statement is **valid**. The solution process will now proceed.\n\n### Solution Derivation\n\nThe analysis requires applying the standard definitions for physiological lung patterns based on PFT results.\n\n**Guiding Principles:**\n\n1.  **Obstructive Ventilatory Defect:** Primarily defined by a reduction in the ratio of Forced Expiratory Volume in $1$ second ($FEV_1$) to Forced Vital Capacity ($FVC$). A common threshold is $FEV_1/FVC  0.70$ or below the lower limit of normal (LLN). Obstructive diseases can lead to air trapping (increased Residual Volume, $RV$) and hyperinflation (increased Total Lung Capacity, $TLC$).\n2.  **Restrictive Ventilatory Defect:** Defined by a reduced Total Lung Capacity ($TLC$), typically below $80\\%$ of the predicted value or below the $5$th percentile. In restriction, $FEV_1$ and $FVC$ are often reduced proportionally, leading to a normal or elevated $FEV_1/FVC$ ratio.\n3.  **Intrinsic vs. Extrinsic Restriction:** This distinction is aided by the $DLCO$.\n    *   **Intrinsic (Parenchymal) Restriction:** Involves the lung tissue itself (e.g., interstitial fibrosis). This impairs gas exchange, resulting in a reduced $DLCO$.\n    *   **Extrinsic Restriction:** Caused by issues outside the lung parenchyma (e.g., chest wall disease, neuromuscular weakness). Gas exchange at the alveolar-capillary membrane is typically preserved, so the $DLCO$ is normal.\n4.  **Technique-Related Artifacts:** Poor spirometric effort, particularly early termination of the forced exhalation, can artificially lower the $FVC$. This can mimic a restrictive pattern on spirometry alone (low $FVC$ with a normal $FEV_1/FVC$ ratio). Measurement of $TLC$ and assessment of quality control indicators are essential to differentiate this from true restriction. A forced expiratory time (FET) of less than $6$ seconds is a key indicator of potential early termination.\n\n**Patient-by-Patient Analysis:**\n\n**Patient Z:**\n- The spirometry values ($FEV_1 = 48\\%$, $FVC = 49\\%$) with a high $FEV_1/FVC$ ratio ($0.98$) suggest a restrictive pattern.\n- However, the quality control data are critical: \"suboptimal; forced expiratory time $= 3$ seconds, early termination noted, poor reproducibility.\" An FET of $3$ seconds is insufficient and indicates the patient did not exhale fully. This invalidates the $FVC$ measurement.\n- The definitive measurement for restriction, the $TLC$, is normal ($98\\%$ predicted). A normal $TLC$ rules out a restrictive ventilatory defect.\n- **Conclusion:** Patient Z does not have restrictive lung disease. The spirometry pattern is a technique-related artifact due to suboptimal effort.\n\n**Patient Y:**\n- The spirometry values ($FEV_1 = 50\\%$, $FVC = 52\\%$) with a high $FEV_1/FVC$ ratio ($0.86$) might initially suggest restriction.\n- However, the lung volume measurements show a markedly elevated $TLC$ of $120\\%$ predicted and a severely elevated $RV$ of $190\\%$ predicted.\n- An elevated $TLC$ indicates hyperinflation, and an elevated $RV$ indicates air trapping. These are hallmark features of obstructive lung disease, not restrictive disease. The low $FVC$ in this context is likely due to dynamic airway collapse and air trapping during forced exhalation.\n- The normal $DLCO$ ($82\\%$ predicted) suggests the obstructive process does not significantly involve destruction of the alveolar-capillary bed (as seen in emphysema) and might be more consistent with a disease like chronic asthma.\n- **Conclusion:** Patient Y has a pattern consistent with obstructive lung disease with significant hyperinflation and air trapping, not restrictive lung disease.\n\n**Patient X:**\n- The spirometry shows a proportional reduction in $FEV_1$ ($55\\%$ predicted) and $FVC$ ($59\\%$ predicted), with a high $FEV_1/FVC$ ratio ($0.93$). This is the classic spirometric picture of restriction.\n- The spirometry quality is good (FET $= 10$ seconds), so the measurements are valid.\n- The lung volume measurement confirms the restrictive defect: the $TLC$ is significantly reduced to $66\\%$ of predicted. This is the definitive finding for restriction.\n- The $DLCO$ is also significantly reduced ($52\\%$ predicted). A reduction in both $TLC$ and $DLCO$ indicates that the restriction is due to a disease process within the lung parenchyma that also affects the alveolar-capillary membrane's ability to transfer gas.\n- **Conclusion:** The combination of a confirmed restrictive defect (low $TLC$) and impaired gas exchange (low $DLCO$) makes Patient X the classic example of **intrinsic (parenchymal) restrictive lung disease**.\n\n### Option-by-Option Analysis\n\n**A. Patient $X$ shows intrinsic restrictive lung disease due to parenchymal involvement.**\n- This option aligns perfectly with our analysis. Patient X has a reduced $TLC$ ($66\\%$), confirming restriction. The associated low $DLCO$ ($52\\%$) indicates a parenchymal (intrinsic) cause.\n- **Verdict: Correct.**\n\n**B. Patient $Y$ shows intrinsic restrictive lung disease.**\n- This option is incorrect. Patient Y has an elevated $TLC$ ($120\\%$), which indicates hyperinflation, the opposite of restriction. The pattern is consistent with obstructive disease.\n- **Verdict: Incorrect.**\n\n**C. Patient $Z$ shows intrinsic restrictive lung disease.**\n- This option is incorrect. Patient Z has a normal $TLC$ ($98\\%$), which rules out a restrictive defect. The spirometric abnormalities are artifacts of a poor-quality test.\n- **Verdict: Incorrect.**\n\n**D. None of the above; all patterns are obstructive or technique-related, not intrinsic restriction.**\n- This option is incorrect because our analysis has clearly identified that Patient X's pattern is most consistent with intrinsic restrictive lung disease.\n- **Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "4970326"}, {"introduction": "To effectively address chronic respiratory diseases on a global scale, we must move beyond individual diagnoses and quantify their collective impact on populations. The Disability-Adjusted Life Year ($DALY$) is a summary measure of population health that captures the total burden of a disease, combining years of life lost to premature mortality ($YLL$) with years lived with disability ($YLD$). This exercise [@problem_id:4970284] guides you through the calculation of these core public health metrics for COPD. This practice is vital for understanding how clinical data on incidence, disability, and mortality are transformed into evidence for policy-making and resource allocation in global health.", "problem": "A public health analyst is estimating the burden of Chronic Obstructive Pulmonary Disease (COPD) in a country for a single calendar year using the disability-adjusted life year framework. The country has population $P=40{,}000{,}000$. New COPD incidence during the year is $I=120$ cases per $100{,}000$ persons per year. For each incident COPD case, the disability weight is $DW=0.17$, and the average duration of disability attributable to COPD is $L_{\\text{dur}}=20$ years. During the year, COPD caused $N=30{,}000$ deaths. The average remaining life expectancy at the age of COPD death is $L_{\\text{rem}}=12$ years.\n\nUse the foundational definitions that Years Lived with Disability (YLD) is the aggregated disability severity integrated over time across cases, Years of Life Lost (YLL) is the aggregated shortfall in life expectancy across deaths, and Disability-Adjusted Life Years (DALY) is the sum of $YLD$ and $YLL$. Derive expressions for $YLD$ per $100{,}000$, $YLL$ per $100{,}000$, and $DALY$ per $100{,}000$ based on these definitions and the given quantities. Express each of $YLD$, $YLL$, and $DALY$ per $100{,}000$ persons in units of years. Provide exact values; no rounding is required.", "solution": "The problem will first be validated against the specified criteria of scientific grounding, well-posedness, and objectivity.\n\n### Step 1: Extract Givens\nThe data, variables, and definitions provided in the problem statement are:\n- Total population: $P=40{,}000{,}000$ persons.\n- New COPD incidence rate: $I=120$ cases per $100{,}000$ persons per year.\n- Disability weight for an incident case: $DW=0.17$.\n- Average duration of disability per incident case: $L_{\\text{dur}}=20$ years.\n- Total deaths from COPD during the year: $N=30{,}000$.\n- Average remaining life expectancy at age of death from COPD: $L_{\\text{rem}}=12$ years.\n- Definition of Years Lived with Disability (YLD): The aggregated disability severity integrated over time across cases.\n- Definition of Years of Life Lost (YLL): The aggregated shortfall in life expectancy across deaths.\n- Definition of Disability-Adjusted Life Years (DALY): The sum of $YLD$ and $YLL$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed based on the validation criteria.\n- **Scientifically Grounded**: The problem utilizes standard, established concepts and metrics from epidemiology and global public health, namely Years Lived with Disability ($YLD$), Years of Life Lost ($YLL$), and Disability-Adjusted Life Years ($DALY$). The formulas for these metrics are standard in the field. The provided values for population, incidence, mortality, and disability are plausible for a large country and a major chronic disease like COPD. The problem is scientifically and factually sound.\n- **Well-Posed**: The problem provides all necessary data and clear definitions to calculate the requested quantities. The task is to compute $YLD$, $YLL$, and $DALY$ on a per-capita basis (per $100{,}000$ persons), for which a unique, stable, and meaningful solution can be determined.\n- **Objective**: The problem is stated in precise, quantitative, and unbiased language. It is free of subjective claims or opinions.\n\n### Step 3: Verdict and Action\nThe problem is scientifically grounded, well-posed, complete, and objective. It does not violate any of the invalidity criteria. Therefore, the problem is deemed **valid**. A complete solution will be provided.\n\n### Solution Derivation\nThe objective is to calculate the Years Lived with Disability ($YLD$), Years of Life Lost ($YLL$), and Disability-Adjusted Life Years ($DALY$), each expressed per $100{,}000$ persons for the specified year.\n\n**1. Calculation of YLD per $100{,}000$ persons**\n\nThe problem provides the parameters for an incidence-based calculation of $YLD$. The total $YLD$ is the product of the number of new (incident) cases, the disability weight of the condition, and the average duration of the disability. We are asked to find this value per $100{,}000$ persons, which we denote as $YLD_{100k}$.\n\nThe incidence rate, $I$, is given as the number of new cases per $100{,}000$ persons per year. For a representative population of $100{,}000$ persons, there will be $I$ new cases in the year. Each of these cases contributes an average of $DW \\times L_{\\text{dur}}$ years of disability over the course of the illness.\n\nThus, the total years lived with disability per $100{,}000$ people is the product of the number of incident cases per $100{,}000$ and the disability years per case:\n$$YLD_{100k} = I \\times DW \\times L_{\\text{dur}}$$\nSubstituting the given values:\n- $I = 120$ cases per $100{,}000$ persons\n- $DW = 0.17$\n- $L_{\\text{dur}} = 20$ years\n\n$$YLD_{100k} = 120 \\times 0.17 \\times 20$$\n$$YLD_{100k} = 120 \\times 3.4$$\n$$YLD_{100k} = 408$$\nThe units are years per $100{,}000$ persons.\n\n**2. Calculation of YLL per $100{,}000$ persons**\n\n$YLL$ is the sum of years of life lost due to premature mortality. To calculate $YLL$ per $100{,}000$ persons ($YLL_{100k}$), we first need the mortality rate per $100{,}000$ persons, which we denote as $M_{100k}$.\n\nThe mortality rate per $100{,}000$ is calculated from the total number of deaths, $N$, and the total population, $P$:\n$$M_{100k} = \\frac{N}{P} \\times 100{,}000$$\nSubstituting the given values:\n- $N = 30{,}000$ deaths\n- $P = 40{,}000{,}000$ persons\n\n$$M_{100k} = \\frac{30{,}000}{40{,}000{,}000} \\times 100{,}000 = \\frac{3}{4{,}000} \\times 100{,}000 = \\frac{300}{4} = 75$$\nSo, there are $75$ deaths per $100{,}000$ persons.\n\nThe $YLL$ per $100{,}000$ persons is the mortality rate per $100{,}000$ multiplied by the average years of life lost per death, $L_{\\text{rem}}$:\n$$YLL_{100k} = M_{100k} \\times L_{\\text{rem}}$$\nSubstituting the calculated $M_{100k}$ and the given $L_{\\text{rem}}$:\n- $M_{100k} = 75$ deaths per $100{,}000$ persons\n- $L_{\\text{rem}} = 12$ years\n\n$$YLL_{100k} = 75 \\times 12$$\n$$YLL_{100k} = 900$$\nThe units are years per $100{,}000$ persons.\n\n**3. Calculation of DALY per $100{,}000$ persons**\n\nThe DALY is defined as the sum of $YLD$ and $YLL$. Therefore, the $DALY$ per $100{,}000$ persons ($DALY_{100k}$) is the sum of $YLD_{100k}$ and $YLL_{100k}$.\n$$DALY_{100k} = YLD_{100k} + YLL_{100k}$$\nSubstituting the calculated values:\n$$DALY_{100k} = 408 + 900$$\n$$DALY_{100k} = 1308$$\nThe units are years per $100{,}000$ persons.\n\nThe final results are:\n- $YLD$ per $100{,}000$ persons = $408$ years.\n- $YLL$ per $100{,}000$ persons = $900$ years.\n- $DALY$ per $100{,}000$ persons = $1308$ years.", "answer": "$$\\boxed{\\begin{pmatrix} 408  900  1308 \\end{pmatrix}}$$", "id": "4970284"}]}